Nephrology

Genetic and specialty testing programs for kidney and renal conditions

Nephrology conditions+

Nephrology includes sponsored testing programs that provide no-cost or low-cost access to genetic and specialty testing for hereditary kidney disorders, glomerular diseases, cystic kidney conditions, and other renal health issues. These programs help identify underlying genetic causes of kidney dysfunction, support more precise diagnosis and management, and connect patients and clinicians with sponsored testing options focused on comprehensive renal evaluation.

5 programs found in Nephrology

Featured Programs

2 programs
Primary Hyperoxaluria Type 1 (PH1)
Alnylam Act
Sponsored by
Alnylam Pharmaceuticals

Alnylam Act® Primary Hyperoxaluria Type 1 (45 genes)

The Alnylam Act® program offers complimentary 45-gene panel testing and genetic counseling for patients with suspected PH1 or a relevant family history (covering AGXT, GRHPR, HOGA1 and additional nephrolithiasis-associated genes). This expanded panel aids you in distinguishing PH1 from related conditions, supporting diagnosis, management pathways and family screening. All services are provided at no charge to the patient, provider or payer.

Nephrology
ViewOrder
Performing labPrevention Genetics
Featured
Primary Hyperoxaluria Type 1 (PH1)
Alnylam Act
Sponsored by
Alnylam Pharmaceuticals

Alnylam Act® Primary Hyperoxaluria Type 1 (3 genes)

The Alnylam Act® program offers complimentary gene‐panel testing and genetic counseling for patients with suspected PH1 (AGXT, GRHPR, HOGA1). The program supports you in confirming diagnosis, guiding patient care and referral, and facilitating family risk assessment. All testing and counseling services are provided at no cost to patients, providers, or payers.

Nephrology
ViewOrder
Performing labPrevention Genetics
Featured

All Other Programs

3 programs
X-linked Hypophosphatemia (XLH)Tumor-Induced Osteomalacia (TIO)

Hypophosphatemia

Sponsored by
Kyowa Kirin Inc.

Kyowa Kirin Sponsored Hypophosphatemia 13 Gene Panel

This program offers no-charge genetic testing and counseling for patients in the US and Canada who may have XLH or TIO and meet age and eligibility criteria. It aims to improve diagnostic accuracy, reduce time to confirmation, and support payer coverage needs. No patients, providers, or payers are billed, and program use does not require recommending or prescribing any Kyowa Kirin therapy.

Nephrology
ViewOrder
Performing labInvitae | Labcorp
Primary Hyperoxaluria (PH)
NovoDETECT
Sponsored by
Novo Nordisk

NovoDETECT Primary Hyperoxaluria Panel

The NovoDETECT program provides clinicians in the US with access to a sponsored genetic test for patients suspected of primary hyperoxaluria (PH). The panel covers major PH-related genes and may clarify diagnosis when clinical or biochemical signs (stones, nephrocalcinosis, elevated oxalate) suggest PH. Results support patient counseling, guide care decisions, and enable genetic counseling — at no cost to patient or provider.

Nephrology
ViewOrder
Performing labBlueprint Genetics
Chronic Kidney Disease (CKD)APOL1-Mediated Kidney Disease (AMKD)

Renasight™

Sponsored by
Vertex Pharmaceuticals

Renasight™ Genetic Kidney Panel

This program offers no-cost Renasight™ testing for eligible patients of African ancestry with chronic kidney disease. It supports early identification of APOL1 risk variants associated with APOL1-mediated kidney disease (AMKD). Providers can use results to inform diagnosis, guide management decisions, and determine whether genetic factors may underlie renal decline.

Nephrology
ViewOrder
Performing labNatera